Table 2.
Clinical Outcomes and Hospital Use in Patients Who Underwent Redo SMVR and ViV TMVR (2015–2018)
| Variable | Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|---|
| Redo SMVR, 2250 | ViV TMVR, 495 | P value | Redo SMVR, 395 | ViV TMVR, 395 | P value | |
| In‐hospital mortality, n (%) | 150 (6.7) | 25 (5.1) | 0.18 | 30 (7.6) | <11 (<2.8) | 0.001 |
| Home discharge, n (%) | 655 (29.1) | 295 (59.6) | <0.01 | 80 (20.3) | 255 (64.6) | <0.01 |
| Skilled nursing care, n (%) | 640 (28.4) | 45 (9.1) | 175 (44.3) | 30 (7.6) | ||
| Home with home health, n (%) | 800 (35.6) | 125 (25.3) | 110 (27.8) | 95 (24.1) | ||
| Cardiogenic shock, n (%) | 460 (20.4) | 45 (9.1) | <0.01 | 95 (24.1) | 25 (6.3) | <0.01 |
| Respiratory complications, n (%) | 305 (13.6) | 60 (12.1) | 0.4 | 80 (20.3) | 45 (11.4) | <0.01 |
| Acute kidney injury, n (%) | 695 (30.9) | 85 (17.2) | <0.01 | 145 (36.7) | 55 (13.9) | <0.01 |
| Stroke, n (%) | 80 (3.6) | <11 (<2.2) | 0.12 | … | <11 (<2.8) | … |
| Vascular complications, n (%) | 40 (1.8) | 30 (6.1) | <0.01 | <11 (<2.8) | 25 (6.3) | 0.01 |
| Blood transfusion, n (%) | 795 (35.3) | 35 (7.1) | <0.01 | 150 (38.0) | 30 (7.6) | <0.01 |
| Cardiac arrest with CPR, n (%) | 15 (0.7) | <11 (<2.2) | 0.004 | … | … | … |
| Prolong mechanical ventilation, n (%) | 165 (7.3) | <11 (<2.2) | <0.01 | 45 (11.4) | <11 (<2.8) | <0.01 |
| Pneumonia, n (%) | 145 (6.4) | <11 (<2.2) | <0.01 | 40 (10.1) | <11 (<2.8) | <0.01 |
| Urinary tract infection, n (%) | 160 (7.1) | 25 (5.1) | 0.1 | 40 (10.1) | 25 (6.3) | 0.05 |
| Pericardial effusion, n (%) | 30 (1.3) | 15 (3.0) | 0.01 | <11 (<2.8) | <11 (<2.8) | 1 |
| PPM, n (%) | 200 (8.9) | <11 (<2.2) | <0.01 | 15 (3.8) | <11 (<2.8) | 0.31 |
| ECMO, n (%) | 70 (3.1) | … | … | <11 (<2.8) | … | … |
| LVAD, n (%) | 20 (0.9) | … | 0.04 | … | … | … |
| ASD transcatheter repair, n (%) | … | 40 (8.1) | <0.01 | … | 35 (8.9) | <0.01 |
| Tricuspid valve replacement, n (%) | 65 (2.9) | … | <0.01 | … | 15 (3.8) | <0.01 |
| Length of stay, d, median (IQR) | 9 (7–15) | 3 (1–8) | <0.01 | 10 (7–16) | 3 (1–8) | <0.01 |
| Cost of hospitalization, $, median (IQR) | 57 800 (42 925–89 776) | 51 675 (3869–67 626) | <0.01 | 57 172 (42 215–86 803) | 52 579 (37 513–69 408) | <0.01 |
The <11 numbers are not reported per data‐provider recommendations.
ASD indicates atrial septal defect; CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; IQR, interquartile range; LVAD, left ventricular assist device; PPM, permanent pacemaker; SMVR, surgical mitral valve replacement; and ViV TMVR, valve‐in‐valve transcatheter mitral valve replacement.